Statement of Principles concerning polycythaemia vera No. 12 of 2013

Administered by Department of Veterans' Affairs

Legislation au F2013L00406 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 12 of 2013

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans’ Entitlements Act 1986 (the VEA), revokes Instrument No. 79 of 1999, as amended by Instrument No. 12 of 2001, determined under subsection 196B(3) of the VEA concerning polycythaemia vera.

 

2.             The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that polycythaemia vera and death from polycythaemia vera can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(3) of the VEA a Statement of Principles, Instrument No. 12 of 2013 concerning polycythaemia vera.  This Instrument will in effect replace the revoked Statements of Principles.

 

3.             The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.

 

4.             The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:

 

 eligible war service (other than operational service) under the VEA;

 defence service (other than hazardous service and British nuclear test defence service) under the VEA;

 peacetime service under the MRCA,

 

before it can be said that, on the balance of probabilities, polycythaemia vera or death from polycythaemia vera is connected with the circumstances of that service.

 

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 24 June 2009 concerning polycythaemia vera in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

 

6.             The contents of this Instrument are in similar terms as the revoked Instruments.  Comparing this Instrument and the revoked Instruments, the differences include:

 

  • adopting the latest revised Instrument format, which commenced in 2005;
  • deleting the ICD code from the Instrument header;
  • revising the definition of 'polycythaemia vera' in clause 3;
  • revising the definitions of 'ICD-10-AM code' and 'relevant service' in clause 6; and
  • specifying a date of effect for the Instrument in clause 8.

 

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

 

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to polycythaemia vera in the Government Notices Gazette of 24 June 2009, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

 

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

 

10.         The determining of this Instrument finalises the investigation in relation to polycythaemia vera as advertised in the Government Notices Gazette of 24 June 2009.

 

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

 

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 12 of 2013

Kind of Injury, Disease or Death: Polycythaemia vera

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have polycythaemia vera;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, polycythaemia vera is connected with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes;
  • replaces Instrument No. 79 of 1999, as amended by Instrument No. 12 of 2001; and
  • reflects developments in the available sound medical-scientific evidence concerning polycythaemia vera which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 12 of 2013, issued under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, addresses the issue of polycythaemia vera, a blood disease, in the context of service-related claims. The Instrument was enacted to formalise the relationship between polycythaemia vera and specific types of military service, based on available medical-scientific evidence. This legislative instrument revokes the previous Statement of Principles No. 79 of 1999, as amended by Instrument No. 12 of 2001, and introduces a new set of criteria for determining the connection between polycythaemia vera and military service, applicable to both the VEA and MRCA. The Authority determined the new Statement of Principles after an investigation and public consultation, ensuring the document reflects the latest medical evidence and complies with human rights obligations under international instruments. The policy objective is to facilitate and standardise the claims process for veterans and service personnel suffering from polycythaemia vera, ensuring that the criteria for compensation are reasonable, proportionate, and transparent.

Scope and Application

The Repatriation Medical Authority Instrument No. 12 of 2013 pertains to the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, establishing a Statement of Principles concerning polycythaemia vera. This legislative instrument applies to individuals who have served in eligible war service, defence service, and peacetime service, as well as their dependents, who are seeking compensation or medical treatment related to polycythaemia vera under the aforementioned Acts. The instrument facilitates the assessment and determination of such claims by outlining the factors that must be present to establish a connection between polycythaemia vera and the service rendered. The instrument is applicable nationally within Australia and replaces the previously revoked Instrument No. 79 of 1999, as amended by Instrument No. 12 of 2001. There are no stated exclusions or exemptions in the instrument, though it does specify the conditions and types of service that must be related to polycythaemia vera for a claim to be considered. The instrument may be further extended or restricted through subordinate instruments as necessary.

Key Provisions

The Repatriation Medical Authority (RMA) has issued Instrument No. 12 of 2013 under the Veterans' Entitlements Act 1986 (VEA) to revise the existing medical guidelines concerning polycythaemia vera, a type of blood disorder. This instrument revokes the previous Instrument No. 79 of 1999, as amended by Instrument No. 12 of 2001, and establishes a new Statement of Principles that reflects the latest medical-scientific evidence available. This Statement of Principles (section 4) outlines the specific circumstances and factors that need to be met to establish a link between polycythaemia vera and particular kinds of military service, including eligible war service, defence service, and peacetime service. The new guidelines aim to facilitate the process of making and assessing claims for compensation and medical treatment under both the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). The Act imposes several obligations on the parties involved. Claimants must provide sufficient evidence to meet the criteria set out in the Statement of Principles to substantiate their claims for compensation. The Repatriation Commission is required to assess these claims based on the updated medical guidelines. Additionally, the Veterans' Review Board and the Administrative Appeals Tribunal have the responsibility to review decisions made by the Repatriation Commission, ensuring that the assessment process is fair and in compliance with the legislative requirements. Breach of the obligations outlined in this legislation can lead to various legal consequences. While the document does not specify particular offences, it is clear that failure to meet the criteria for compensation or providing false information could result in the denial of claims. Furthermore, any individual or entity found to be deliberately misleading in the claims process might face additional scrutiny and potential legal action. The specific penalties for such breaches are not detailed in the explanatory notes, but they could include fines or other legal sanctions as determined by the relevant authorities. The overarching goal of the legislation is to ensure that the rights of veterans and service personnel are protected and that compensation is awarded based on sound medical evidence.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.